ライフサイエンスコーパス: beta-adrenergic agonist

1 her increase by a standard inhaled dose of a beta-adrenergic agonist.

2 hase of LTP also is modulated importantly by beta-adrenergic agonists.

3 iates abbreviation of systole in response to beta-adrenergic agonists.

4 drenergic agonists and dilate in response to beta-adrenergic agonists.

5 notype in white adipose tissue stimulated by beta-adrenergic agonists.

6 and its inhibitory effect can be reversed by beta-adrenergic agonists.

7 ble for the increase in heart rate caused by beta-adrenergic agonists.

8 hich responds to low doses of cholinergic or beta-adrenergic agonists.

9 ate vectorial fluid transport in response to beta-adrenergic agonists.

10 in regulating portal vein responsiveness to beta-adrenergic agonists.

11 beta-Adrenergic agonists accelerate the clearance of alv

12 4, Y364), although both growth factors block beta-adrenergic agonist action.

13 Bucindolol exhibits approximately 60% of the beta-adrenergic agonist activity of xamoterol in normal

14 abain, high Ca(2+), lysophosphatidylcholine, beta-adrenergic agonist, acylcarnitine, and the Ca(2+) i

15 We have previously shown that beta-adrenergic agonists affect Na+-K+ pump current (Ip)

16 r isoproterenol, a rapidly acting peripheral beta-adrenergic agonist akin to adrenaline, or saline.

17 Isoproterenol, the beta-adrenergic agonist, also elicited protein secretion

18 to generate docked complexes for a series of beta adrenergic agonists and antagonists with a three-di

19 We examined the effect of beta-adrenergic agonists and antagonists on action poten

20 otein, termed betaARB protein, is induced by beta-adrenergic agonists and binds to beta2-receptor mRN

21 RNA binding protein (beta ARB) is induced by beta-adrenergic agonists and binds to G-protein-linked r

22 ial dysfunction, which can be prevented with beta-adrenergic agonists and cAMP.

23 -deficient mice, the contractile response to beta-adrenergic agonists and extracellular calcium is re

24 Both beta-adrenergic agonists and insulin provoke sequestrati

25 uscle and regulate other cellular functions, beta-adrenergic agonists and nitric oxide-containing com

26 in mouse hearts exposed to isoproterenol, a beta-adrenergic agonist, and isoproterenol-induced incre

27 ion inhaled corticosteroids with long-acting beta-adrenergic agonists, and anti-IgE.

28 , in the rodent, by factors such as insulin, beta-adrenergic agonists, and glucocorticoids (GCs).

29 n response to adenosine, prostaglandin E(2), beta-adrenergic agonists, and other mediators, is a mean

30 Inhaled beta-adrenergic agonists are the most commonly used medi

31 Caffeine and beta-adrenergic agonists are well-recognised drugs that

32 ervous system (SNS) and can be stimulated by beta-adrenergic agonists, at least in animals.

33 rge-White)) were administered Ractopamine (a beta-adrenergic agonist; BA; 20 ppm in feed) or Reporcin

34 Administration of beta-adrenergic agonist bronchodilators to patients with

35 ngineered a Frizzled-2 chimera responsive to beta-adrenergic agonist by using the ligand-binding doma

36 We computed bias factors for a number of beta-adrenergic agonists by comparing BRET assays of rec

37 can attenuate responses of cardiomyocytes to beta-adrenergic agonists by decreasing PLN phosphorylati

38 including leukotriene modifiers, long-acting beta-adrenergic agonists, combination inhaled corticoste

39 We studied whether beta-adrenergic agonists could restore lung edema cleara

40 eoblasts regulate their proliferation, and a beta-adrenergic agonist decreases bone mass in leptin-de

41 The beta-adrenergic agonist dobutamine was infused via a per

42 ip, and blunted contractile responses to the beta-adrenergic agonist dobutamine.

43 hearts but was normalized with supply of the beta-adrenergic agonist dobutamine.

44 Two clinically relevant beta-adrenergic agonists, dopamine (beta-1 agonist) and

45 The beta-adrenergic agonist failed to elicit a significant n

46 Isoproterenol (beta-adrenergic agonist) failed to alter plasma leptin b

47 beta-Adrenergic agonists have been selected as model com

48 le treatments of inhaled corticosteroids and beta-adrenergic agonists; however, 5-10% have severe dis

49 The modulation of the exchanger by a beta-adrenergic agonist in whole-cell clamped ventricula

50 ow responses to brachial artery infusions of beta-adrenergic agonists in healthy men.

51 ity of peripheral blood mononuclear cells to beta-adrenergic agonists in patients with heart failure

52 beta-adrenergic agonists increase active Na(+) transport

53 Beta-adrenergic agonists increase ATPase activity throug

54 beta-adrenergic antagonists, indicating that beta-adrenergic agonists increase the metabolism of BAT.

55 Both alpha1- and beta-adrenergic agonists increase the severity of global

56 The data suggest that beta-adrenergic agonists increased alveolar fluid reabso

57 Beta-adrenergic agonists induce protein kinase A (PKA) p

58 oponin I (cTnI) contributes significantly to beta-adrenergic agonist-induced acceleration of myocardi

59 beta-Adrenergic agonist-induced desensitization was sign

60 s blocks L-LTP; conversely, application of a beta-adrenergic agonist induces the L-LTP.

61 aseline temperature was seen before or after beta-adrenergic agonist injection.

62 In combination with beta-adrenergic agonists, insulin stimulates internaliza

63 er small infusions of isoproterenol (ISO), a beta-adrenergic agonist, into MS alter behavioral, EEG,

64 of amylase secretion from parotid glands by beta-adrenergic agonists is mediated by the activation o

65 Additional administration of the beta-adrenergic agonist isoprenaline (1 microM) or the m

66 The beta-adrenergic agonist isoprenaline (10 microM) also ac

67 gic responses, the sensitivity of ICa to the beta-adrenergic agonist isoprenaline (Iso) was studied i

68 hibited the Ca(2+) current stimulated by the beta-adrenergic agonist isoprenaline (Iso), and washout

69 current (ICa,L) previously stimulated by the beta-adrenergic agonist isoprenaline (Iso).

70 d vessels were treated with the nonselective beta-adrenergic agonist isoproterenol (10(-5) M), both a

71 hythmogenic index, 4.10; n = 8 cells) or the beta-adrenergic agonist isoproterenol (arrhythmogenic in

72 eased lipolysis in response to 10 muM of the beta-adrenergic agonist isoproterenol (by 42%), 10 muM o

73 subthreshold concentration (1 nmol/L) of the beta-adrenergic agonist isoproterenol (Iso), genistein c

74 sitivity of the Cl- current to the selective beta-adrenergic agonist isoproterenol (Iso), which indic

75 m nitroprusside (0.1 mmol/L), suppressed the beta-adrenergic agonist isoproterenol (ISO, 1 mumol/L)-s

76 The beta-adrenergic agonist isoproterenol (ISO; 1 muM) incre

77 MP) in the pipette or in the presence of the beta-adrenergic agonist isoproterenol (isoprenaline; ISO

78 been treated in vivo with milrinone, to the beta-adrenergic agonist isoproterenol and the muscarinic

79 Using the beta-adrenergic agonist isoproterenol as a specific path

80 e integrated syncytium was responsive to the beta-adrenergic agonist isoproterenol as well as to othe

81 For comparison, the beta-adrenergic agonist isoproterenol caused a 38 % incr

82 m the membrane induced by cholera toxin, the beta-adrenergic agonist isoproterenol caused a rapid par

83 ication of noradrenaline or of the selective beta-adrenergic agonist isoproterenol decreased gap junc

84 Challenge of Zmpste24(-/-) mice with the beta-adrenergic agonist isoproterenol did not trigger ve

85 The beta-adrenergic agonist isoproterenol failed to increase

86 The beta-adrenergic agonist isoproterenol increased lung liq

87 Here, we found that the beta-adrenergic agonist isoproterenol induced mature bet

88 t induce LTP, but the addition of either the beta-adrenergic agonist isoproterenol or the cAMP analog

89 In both rat and human strips, the full beta-adrenergic agonist isoproterenol raised cAMP levels

90 Stimulation of LQT2 cells with beta-adrenergic agonist isoproterenol resulted in prolon

91 Membrane-permeable 8-bromo-cAMP and the beta-adrenergic agonist isoproterenol significantly reve

92 pressing the chimera (beta2AR-Rfz1) with the beta-adrenergic agonist isoproterenol stimulated stabili

93 ino]-5'-N-ethylcarboxamidoadenos ine and the beta-adrenergic agonist isoproterenol were additive, ind

94 P levels (including PGE2, forskolin, and the beta-adrenergic agonist isoproterenol) can inhibit P2Y r

95 synaptic stimulation in the presence of the beta-adrenergic agonist isoproterenol, a combination tha

96 ttenuates the vasorelaxation response to the beta-adrenergic agonist isoproterenol, without affecting

97 nsients caused by high concentrations of the beta-adrenergic agonist isoproterenol.

98 and it was blocked in cells pretreated with beta-adrenergic agonist isoproterenol.

99 cAMP levels that were pre-elevated with the beta-adrenergic agonist isoproterenol.

100 ardiomyocytes following stimulation with the beta-adrenergic agonist isoproterenol.

101 xtended to describe myocyte responses to the beta-adrenergic agonist isoproterenol.

102 e beta-adrenergic blocker metoprolol and the beta-adrenergic agonist isoproterenol.

103 d a dose-dependent inotropic response to the beta-adrenergic agonist isoproterenol.

104 revented the Mg(2+) extrusion induced by the beta-adrenergic agonist isoproterenol.

105 Intraperitoneal injection of a beta-adrenergic agonist (isoproterenol) enhances SIRT2 e

106 KA) in VSMC as profoundly as the G(s)-linked beta-adrenergic agonist, isoproterenol (ISO), but in a t

107 gonist, clonidine (CLON; 0.6 mg/kg BW), or a beta-adrenergic agonist, isoproterenol (ISO; 0.2 mg/kg B

108 hibits PKA activities at the SR induced by a beta-adrenergic agonist, isoproterenol, and subsequently

109 A single injection of the beta-adrenergic agonist, isoproterenol, induced a dramat

110 Pretreatment with a beta-adrenergic agonist, isoproterenol, or a cAMP analog

111 enylyl cyclase activator, forskolin, and the beta-adrenergic agonist, isoproterenol, to lamina A1 of

112 and attenuated contractile responses to the beta-adrenergic agonist, isoproterenol.

113 eased amount of high affinity binding of the beta-adrenergic agonist, isoproterenol.

114 ling activated by parathyroid hormone or the beta-adrenergic agonist, isoproterenol.

115 protein, vasoactive intestinal peptide, and beta-adrenergic agonists, like isoproterenol.

116 The combined alpha- and beta-adrenergic agonist norepinephrine (NE) activated th

117 This study evaluated the effect of various beta-adrenergic agonists on (18)F-FDG uptake in brown ad

118 ies to investigate the actions of alpha- and beta-adrenergic agonists on Na+-K+ pump current.

119 l to the inotropic and lusitropic effects of beta-adrenergic agonists on the heart.

120 effects of ephedrine sulfate, an alpha- and beta-adrenergic agonist, on subjective and physiological

121 t E1 state was observed after treatment with beta-adrenergic agonist or with coexpression of phosphom

122 ts that increase intracellular cAMP, such as beta-adrenergic agonists or Bt2cAMP itself, decreased ob

123 angiocyte secretion in response to secretin, beta-adrenergic agonists, or changes in [HCO(3)(-)](i),

124 rdiomyocytes from GRK5-knockout (KO) mice to beta-adrenergic agonists, pretreatment of GRK5-KO cardio

125 These studies indicate that cAMP and beta-adrenergic agonists produce distinct short and long

126 dings suggest that the suppressive effect of beta-adrenergic agonists requires the presence of the P-

127 Administration of beta-adrenergic agonist restored the expression of presy

128 Beta-adrenergic agonists restored AFR in rats exposed to

129 ce were small and insensitive to insulin and beta-adrenergic agonists resulting in reduced adipocyte

130 cits because intra-hippocampal injections of beta-adrenergic agonists reversed cell death.

131 d isoproterenol, a rapidly acting peripheral beta-adrenergic agonist similar to adrenaline, to induce

132 to intravenous infusions of isoproterenol, a beta-adrenergic agonist similar to adrenaline.

133 Beta-adrenergic agonists stimulate cardiac contractility

134 a novel role for TGF-beta1 in impairing the beta- adrenergic agonist-stimulated alveolar fluid clear

135 regulates both peripheral vascular tone and beta-adrenergic agonist-stimulated cardiac contractility

136 Although it is well known that beta-adrenergic agonist stimulation increases alveolar e

137 levated basal lipolysis that is resistant to beta-adrenergic agonist stimulation, and are cold-sensit

138 The beta-adrenergic agonist terbutaline produced changes in

139 ithelial cells were treated with cAMP or the beta-adrenergic agonist terbutaline, a biphasic AQP5 res

140 idney cell stimulation with isoproterenol, a beta-adrenergic agonist that activates adenylyl cyclase,

141 Bath application of isoproterenol (1 muM), a beta-adrenergic agonist that activates PKA, significantl

142 HR) after administration of isoproterenol, a beta-adrenergic agonist that increases circulating level

143 portantly, 3OST2 transcription is blocked by beta-adrenergic agonists that activate the pineal melato

144 Pharmacological treatment with a beta-adrenergic agonist to stimulate lipolysis evoked a

145 cyclase pathway, attenuating the ability of beta-adrenergic agonists to act following stimulation of

146 ed exposure to cognitive novelty and/or oral beta-adrenergic agonists to lessen the effects of Abeta

147 ty of both beta(3)-selective and nonspecific beta-adrenergic agonists to stimulate lipolysis is marke

148 The stimulation of lipolysis by beta-adrenergic agonists triggers rapid phosphorylation

149 DR), and torsade de pointes (TdP) induced by beta-adrenergic agonists under conditions mimicking the

150 ered as relevant in the context of detecting beta-adrenergic agonists use in animals.

151 structural similarities of NNK with classic beta-adrenergic agonists, we tested the hypothesis that

152 ctile parameters and inotropic response to a beta-adrenergic agonist were measured in isolated trabec

153 the bilayer by isoproterenol, a nonspecific beta adrenergic agonist, were both blocked by pretreatme

154 ng inotropic and lusitropic tachyphylaxis to beta-adrenergic agonist, which likely contributes to its

155 ludes extrarenal factors such as insulin and beta-adrenergic agonists, which stimulate the movement o

156 an exogenous NO donor), and isoproterenol (a beta-adrenergic agonist whose vasodilator effect stems f

157 ced by stimulation of isoproterenol (ISO), a beta-adrenergic agonist with a peak at approximately 12

158 , HCO(3)(-)/CO(2), cholinergic agonists, and beta-adrenergic agonists, with or without selected inhib

159 Mice chronically fed a beta-adrenergic agonist without EE were protected from h